Detrás de los titulares sobre el cáncer

Estudio: La extirpación temprana de los ovarios puede estar relacionada con un pequeño aumento en el riesgo de enfermedad de Parkinson a edad avanzada

The lifetime risk of developing Parkinson’s disease is low. However, having surgery to remove both ovaries before natural menopause can slightly increase the risk of Parkinson's disease later in life. Researchers studied over 20 years of medical records, which confirmed this small increase in risk, particularly for women who have their ovaries removed before age 43. (Posted 5/3/23)

Este artículo está disponible en español.

Estudio: Los anticonceptivos hormonales pueden reducir el riesgo de cáncer de ovario en personas con mutaciones en BRCA

Hormonal birth control pill is linked to reduced ovarian cancer among people with an inherited BRCA mutation. Longer-acting forms of birth control given by implant, injection or as an intrauterine device may be associated with lower ovarian cancer risk for people with an inherited BRCA mutation. (Posted 4/28/23)

Este artículo está disponible en español.

Estudio: Los productos para alisar el cabello se relacionan con un ligero aumento del riesgo de cáncer de endometrio

Many people use products to straighten their hair. Use of these products, especially frequent use, is linked to a small increase in endometrial cancer.  (Posted 4/18/23)

Este artículo está disponible en español.

Estudio: Los resultados del cáncer de mama mejoraron con un tratamiento específico

A study showed that people with metastatic breast cancer who took an oral drug known as a CDK4/6 inhibitor combined with hormone therapy did better than people who took hormone therapy alone. The drug combination improved the length of time before cancer worsened or returned. After six years of treatment, people who took this drug combination lived longer compared to those who took hormone therapy alone. (Posted 4/5/23)

Este artículo está disponible en español.

Estudio: El peso puede afectar el riesgo de padecer cáncer de mama en las mujeres con una mutación hereditaria en el gen BRCA

A study that looked at normal breast cells from women with an inherited BRCA mutation found more DNA damage among women who were overweight (based on a measurement known as body mass index) than those who were not overweight. The results suggest that maintaining a lower weight may reduce breast cancer among this high-risk population. (Posted 3/30/23)

Este artículo está disponible en español.

Estudio: Nuevo tratamiento con un medicamento oral contra el cáncer de mama avanzado

The FDA has approved a new oral drug called Oserdu for the treatment of HR-positive, HER2-negative advanced breast cancer. A blood test was also approved to help doctors identify patients who would benefit most from this new treatment. (Posted 3/20/23)

Este artículo está disponible en español.

Estudio: El racismo sistémico puede retardar el procedimiento de biopsia de mama en las personas de raza negra y asiática

Black and Asian people are more likely to have to wait more than 90 days between an abnormal mammogram and a biopsy compared to white people. After accounting for other factors, the authors conclude that these disparities may be due to systemic racism. (Posted 3/8/23)

Este artículo está disponible en español.

Estudio: Prometedores resultados iniciales para tratar el cáncer de próstata metastásico.

The TALAPRO studies looked at how well the oral drug Talzenna (talazoparib) works as a treatment for metastatic castration-resistant prostate cancer (mCRPC). The addition of Talzenna to treatment with Xtandi (enzalutamide) increased the time until the cancer got worse or came back (progression-free survival). The greatest benefit was seen in people who had an inherited or tumor mutation in a gene that repairs DNA damage (such as ATM, BRCA1, BRCA2 and others). (Posted 3/1/23)

Update: On June 20, 2023, the Food and Drug Administration (FDA) approved the combination of Talzenna with Xtandi as an initial treatment for some people with mCRPC for people with inherited or tumor mutations in genes that repair DNA damage. 

Este artículo está disponible en español.

Estudio: El tratamiento para reducir las fracturas óseas también mejora la supervivencia al cáncer de mama en personas posmenopáusicas

A large study looked at the effects of adding the bone-protective drug denosumab (Prolia), to standard hormone therapy for the treatment of early-stage, postmenopausal, HR-positive breast cancer. The researchers found that adding denosumab to aromatase inhibitor hormonal therapy improved bone health, disease-free survival and overall survival. (Posted 2/27/23)

Este artículo está disponible en español.

Estudio: Aumentar el consumo de soya en su dieta puede disminuir su riesgo de cáncer

This study looked at a link between a diet rich in soy and cancer risk. With the addition of more recent literature, this study suggests that soy lowers the risk of cancer in the general population. (Posted 2/24/23)

Este artículo está disponible en español.